APPLICATION
NDA013615
TYPE
NDA
ORIGINAL APPROVAL
1969-02-03
LATEST ACTION
1981-06-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
QUIDEDiscontinued
PIPERACETAZINE 25MG · TABLET · ORAL
QUIDEDiscontinued
PIPERACETAZINE 10MG · TABLET · ORAL
Approval history
1981-06-19Labeling · Supplement 32 · standardAP
1980-09-08Labeling · Supplement 31 · standardAP
1980-03-12Labeling · Supplement 30 · standardAP
1979-08-13Labeling · Supplement 29 · standardAP
1978-07-24Manufacturing (CMC) · Supplement 28 · standardAP
1975-02-03Labeling · Supplement 25 · standardAP
1969-02-03Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.